Social Media

Stay up-to-date with the latest news and events by following Weill Cornell Medicine on social media. You’ll find a variety of posts covering healthcare news, research breakthroughs and education on each platform. Our feeds also include updates from faculty, students, departments, institutes, centers, units and other groups, which you can follow in turn. Just look for the “WCM” icon!

Users who interact with any social media property of Weill Cornell Medicine are bound by the Weill Cornell Medicine and Cornell University social media policies, see links at right. It is important to note that these guidelines may be applicable for employees outside of work and other users when making reference to Weill Cornell Medicine.

Instructions for Weill Cornell Medicine faculty, staff and students about WCM social media registration & internal policy.

WCM Social Media Guidelines

Cornell University Policy 4.16, "University Social Media Accounts"

Twitter

Tweets by @WeillCornell

Facebook

Weill Cornell Medicine

Instagram

At this time tomorrow, the Class of #WCM2022 will have their very own white coats! Be sure to tag your photos using #WhiteCoatCeremony & #WCM2022

This image shows macrophages (red), a type of white blood cell, infected with Mycobacterium tuberculosis (green and blue). Photo credit: Dr. Helene Botella, an instructor in microbiology and immunology @weillcornell.

WCM investigators may have discovered a way to accelerate treatment for #tuberculosis (TB) and possibly overcome growing resistance to existing therapies. In a study published in Science Translational Medicine, Dr. Dirk Schnappinger and colleagues found a way to subvert the waxy coating surrounding Mycobacterium tuberculosis (Mtb), the bacterium that causes TB, making it easier for antibiotics to get inside and kill them. The investigators, including those from a National Institute of Allergy and Infectious Disease Tuberculosis Research Unit – a six-institution multidisciplinary collaboration led by WCM – tested the strategy in culture with an experimental drug and in mice that were infected with genetically manipulated Mtb. The group found that the approach made a known TB drug more potent, potentially speeding up treatment.
#TuberculosisResearch #TB #CareDiscoverTeach #WeillCornellMedicine

Join us in celebrating the 25th anniversary of a momentous summer program, Gateways to the Laboratory. In 1993, the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD program established the Gateways to the Laboratory Summer Program to not only train students to become successful MD-PhD applicants but also to increase the number of underrepresented minority and disadvantaged people who aim to pursue this combined degree.

Pictured: 2018 keynote speaker and Gateways alum, Harvard Medical School Professor Jonathan Abraham (MD-PhD), Tri-I MD-PhD Program Director Olaf S. Andersen (MD), and Assistant Dean for Mentoring at WCM Ruth Gotian (Ed.D) with the Gateways Class of 2018.

Pictured: the first class of students in the ACCESS summer program - Class of 1993 and this year's class of 2018.
Congratulations to the ACCESS Summer Program on 25 years of enhancing biomedical knowledge in undergraduate students! As our summer research programs conclude, the ACCESS Program ended with a celebratory award ceremony to showcase students’ research. “Observing a lack of diversity in the biomedical sciences, leaders at @WeillCornellGS recognized early on the need to expose students who are underrepresented in science to the best training environments. The ACCESS program not only provided that exposure but also summer stipends, housing, personal advising, and a range of graduate school preparatory workshops. It makes me very proud to be a part of this 25 year legacy of access, opportunity, and mentorship,” says Dr. W. Marcus Lambert, ACCESS Program Director and Assistant Dean of Diversity and Student Life.

ACCESS encourages applications from students traditionally underrepresented in research careers in the sciences, social sciences and humanities, students with disabilities, and students from disadvantaged backgrounds

#Diversity #PreMedEd #PhD #WeAreWCM #WeillCornellMedicine #CareDiscoverTeach

As the summer programs wind down at Weill Cornell Medicine, we celebrate the Travelers Summer Research Fellowship Program (T-SRF) in honor of their 50th anniversary. Travelers is a seven- week immersive experience in medicine and research that brings together aspiring physicians – most of whom are members of underrepresented minorities – to Weill Cornell each summer. Founded five decades ago amid the societal shifts of the civil rights movement, Travelers—which is named in honor of the foundation that supports it—is believed to be the longest-running program of its kind in the U.S. The program is open to anyone with a demonstrated interest in aiding medically under-served communities.
Dr. Elizabeth A. Wilson-Anstey, director of the program and Assistant Dean of #Diversity & Student Life, stands with the students of the 2018 class on their final day. “It has been my privilege and good fortune to have interacted with hundreds of premedical students who participated in the T-SRF program. I hope the number of participants in the program increases in the coming years. The effectiveness of the T-SRF in preparing premedical students for a career in medicine is well-documented,” said Dr. Wilson-Anstey.
#TBT #Diversity #PreMedEd #WeAreWCM #WeillCornellMedicine #CareDiscoverTeach

WCM & @nyphospital's Dr. Richard Isaacson teamed up with @SethRogen and @LaurenMillerRogen of @HilarityforCharity to increase #alzheimers prevention efforts and promote #brainhealth education. Check out this #BehindTheScenes shot from our shoot! To learn more about these efforts, stay tuned on alzu.org for updates.
#MedEd #AlzheimersAwareness #CareDiscoverTeach

Renowned obstetrician Dr. Laura Riley has been appointed chair of the Department of Obstetrics and Gynecology at Weill Cornell Medicine and obstetrician and gynecologist-in-chief @nyphospital. Dr. Riley will lead the state-of-the-art NewYork-Presbyterian Alexandra Cohen Hospital for Women and Newborns, which will comprise the top five-and-a-half floors of the NewYork-Presbyterian David H. Koch Center when the NYP Cohen Hospital opens in 2020.
Dr. Riley will seek to expand research efforts at the Department of Obstetrics and Gynecology, mentor junior faculty and provide exemplary training to the next generation of obstetricians and gynecologists. “Weill Cornell Medicine and NewYork-Presbyterian provide outstanding care. This role gives me an opportunity to build an even more exceptional clinical service and mentor junior faculty as they progress in their careers. As an underrepresented minority physician-leader, it demonstrates that there are no limits to advancing in medicine.” #WeAreWCM #WeillCornellMedicine

This is a microscopy image of a early stage human NSCLC, where tumor cells (cyan) show expression of PD-L1 (yellow). Also present are T cells (red) expressing PD-1 (blue). Photo credit: Mittal Lab

Drs. Vivek Mittal and Nasser Altorki found that treating early-stage lung cancers with drugs that unleash the immune system’s ability to attack malignant cells may hinder tumor growth and improve overall survival. The findings suggest that immunotherapy blocking PD-1 – a protein that inhibits immune response to tumors – could be successfully incorporated into the treatment for early-stage non-small cell lung cancer (NSCLC), in addition to late-stage treatment, according to their study published in JCI Insights.

These findings would allow for the initiation of immunotherapy earlier in the course of this cancer, giving clinicians access to take advantage of patients’ immune systems while they are still healthy, compared to trying to treat after a tumor has progressed.
#immunotherapy #NSCLC #lungcancer #CareDiscoverTeach #WeillCornellMedicine

This image shows fluorescent chromosome staining, revealing genetic abnormalities in blood cells. Photo credit: Dr. Susan Mathew
#TBT to a study by WCM & @nyphospital investigators, which found that gene mutations detected in blood may predict the risk of acute myeloid leukemia (AML) a decade before patients would normally be diagnosed. This paper was the first to describe a genomic pre-malignant phase of the cancer, a disease in which the bone marrow makes abnormal white blood cells. AML is one of the most common forms of adult leukemia and oftentimes is developed suddenly. These findings could aid investigators in developing new targeted therapies and strategies to advance the diagnosis of this disease. “Our findings provide an unprecedented opportunity to start thinking about ways to intercept AML to delay or prevent it before it develops in patients at risk,” said co-senior author Dr. Gail Roboz, professor of medicine and director of the Weill Cornell Leukemia Program.
#AML, #Leukemia #Science #Research #CareDiscoverTeach #WeillCornellMedicine

This photo demonstrates #prostate #organoids from genetically engineered mouse models.
Conventional wisdom suggests that a high level of the protein prostate specific antigen (#PSA) in men with #prostatecancer means a poor prognosis. However, this may not always be the case in men with a particular subtype of prostate cancer, according to a new study published in the Journal of Clinical Oncology Precision Oncology by WCM and @nyphospital researchers.
Researchers hope to use these findings to better understand how doctors can use #PSA scores and the identification of prostate cancer subtypes to guide patient care.

Welcome to all the residents starting this week at WCM and @nyphospital. Leaders like Dr. Orli R. Etingin, who was chief medical resident from 1986-87, and Dr. John P. Leonard, who was chief medical resident from 1996-97 were once in your shoes. #TBT to the beginning of Dr. Etingin and Dr. Leonard’s journeys to becoming WCM’s healthcare leaders. #WeAreWCM #CareDiscoverTeach #WomeninSTEM

Our Location

Newsroom

Twitter
Facebook
LinkedIn
Instagram
YouTube
Vimeo

Weill Cornell Medicine
Office of External Affairs

1300 York Ave.
Box 314
New York, NY 10065
Phone: (646) 962-9564

News+
Press Room+
Publications+
- Weill Cornell Medicine Magazine
Video & Photography+
- Photography
- Videos
Social Media+
- Social Media Guidelines
About Us+
- Contact Request Form
- Staff Directory

Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.

Weill Cornell Medicine

Privacy & Legal
Careers
Giving
Directory
Web Accessibility Assistance

You are here

Social Media

Twitter

Facebook

Instagram